(WTIU) UBS ETRACS - ProShares - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US06368L3042 • Trading--Leveraged Commodities

WTIU: Commodities, Energy, Exchange-Traded, Equity, Oil, Trading, Investment

UBS ETRACS - ProShares Daily 3x Long Crude ETN (WTIU) is designed to deliver three times the daily performance of the underlying index, offering leveraged exposure to crude oil prices. The ETN resets its leverage daily, meaning returns over multiple days are path-dependent and can diverge significantly from three times the indexs long-term returns due to compounding effects. The product is subject to a Daily Investor Fee, Daily Financing Charge, and potential Redemption Fee, which collectively reduce returns. The notes are structured to reflect this enhanced exposure on a daily basis, but investors should be aware that holding periods longer than one day may result in returns that differ materially from triple the indexs performance.

The ETN tracks crude oil prices through a futures-based index, providing exposure to one of the most widely traded commodities. It is designed for short-term trading strategies, given its daily reset mechanism, and is not suitable for long-term investment horizons due to the potential for significant deviations from triple the indexs returns over extended periods. The product is traded on the NYSE ARCA under the ticker WTIU, with a modest AUM of $8.63 million, indicating limited institutional participation but sufficient liquidity for retail traders.

3-Month Forecast: - Price Action: Based on the SMA crossover and ATR, WTIU is likely to experience volatility-driven price swings. The SMA 20 ($12.16) and SMA 50 ($11.66) suggest near-term resistance, while the SMA 200 ($14.97) indicates longer-term downside potential. The ATR of 3.33 implies daily price movements could remain elevated. - Volatility: Expect continued elevated price fluctuations due to crude oil market dynamics and the 3x leverage factor. The ATR suggests that daily price changes could remain significant, potentially exceeding 20% during periods of high market stress. - Liquidity: With an average 20-day volume of 19,192 shares, WTIU may face liquidity challenges during periods of high market volatility, potentially leading to wider bid-ask spreads and reduced trading efficiency.

Additional Sources for WTIU ETF

WTIU ETF Overview

Market Cap in USD 9m
Category Trading--Leveraged Commodities
TER 0.95%
IPO / Inception 2017-01-04

WTIU ETF Ratings

Growth Rating -62.4
Fundamental -
Dividend Rating 0.0
Rel. Strength -56.5
Analysts -
Fair Price Momentum 5.63 USD
Fair Price DCF -

WTIU Dividends

No Dividends Paid

WTIU Growth Ratios

Growth Correlation 3m -51.5%
Growth Correlation 12m -89.9%
Growth Correlation 5y -57.7%
CAGR 5y -35.89%
CAGR/Max DD 5y -0.47
Sharpe Ratio 12m 0.51
Alpha -79.84
Beta 2.455
Volatility 90.30%
Current Volume 5.6k
Average Volume 20d 12.1k
What is the price of WTIU stocks?
As of May 22, 2025, the stock is trading at USD 8.28 with a total of 5,552 shares traded.
Over the past week, the price has changed by -13.95%, over one month by +14.76%, over three months by -35.19% and over the past year by -60.73%.
Is UBS ETRACS - ProShares a good stock to buy?
No, based on ValueRay Analyses, UBS ETRACS - ProShares (NYSE ARCA:WTIU) is currently (May 2025) a stock to sell. It has a ValueRay Growth Rating of -62.43 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WTIU as of May 2025 is 5.63. This means that WTIU is currently overvalued and has a potential downside of -32%.
Is WTIU a buy, sell or hold?
UBS ETRACS - ProShares has no consensus analysts rating.
What are the forecast for WTIU stock price target?
According to ValueRays Forecast Model, WTIU UBS ETRACS - ProShares will be worth about 6.8 in May 2026. The stock is currently trading at 8.28. This means that the stock has a potential downside of -18.36%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 6.8 -18.4%